Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Tong

Showing results (451-460 of 479) with videos related to

Pageof 48
Sort By:
Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCVAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitorsWensheng Yu, Ling Tong, Seong Heon Kim, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
The Journal of Antibiotics|February 5, 2015
A new antibiotic with potent activity targets MscLIrene Iscla, Robin Wray, Paul Blount, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose ProjectionsH Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
Pageof 48

Showing results (451-460 of 479) with videos related to

Sort By:
Pageof 48
Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCVAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitorsWensheng Yu, Ling Tong, Seong Heon Kim, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2016
Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
The Journal of Antibiotics|February 5, 2015
A new antibiotic with potent activity targets MscLIrene Iscla, Robin Wray, Paul Blount, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose ProjectionsH Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
Pageof 48